Trial halted: early test of Heart-Kidney drug ends prematurely
NCT ID NCT06611423
Summary
This was an early, small study to see if a single dose of an experimental drug called AZD3427 could improve blood flow to the kidneys in people who have both heart failure and reduced kidney function. Researchers used special PET scans to measure blood flow before and after the dose. The study was terminated early and only enrolled 10 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Solna, 171 64, Sweden
Conditions
Explore the condition pages connected to this study.